Literature DB >> 20305878

Anatomopathological study of cardiomyopathy induced by doxorubicin in rats.

José Carlos Dorsa Vieira Pontes1, Jandir Ferreira Gomes Júnior, Guilherme Viotto Rodrigues da Silva, Ricardo Adala Benfatti, Amaury Edgardo Mont'serrat Avila Souza Dias, João Jackson Duarte, Neimar Gardenal, Maçanori Odashiro, Carlos Henrique Marques dos Santos.   

Abstract

PURPOSE: The development of an experimental model of myocardiopathy induced by Doxorubicin in rats.
METHODS: 16 wistar male rats were randomized in two groups: Group I (placebo) and Group II (Doxorubicin - 5mg/kg). After six months, the animals were subjected to cardiotomy and their hearts were weighted and submitted to transversal cuts, from which fragments for a macro and micro study were obtained. These fragments were studied considering their external and internal diameters and the thickness of the left ventricle (LV). The histological pieces were analyzed for the presence of fibrosis, cytoplasmic vacuolization, necrosis and size of nucleus variation. Data obtained was submitted to statistical analysis with Student's t test.
RESULTS: The hearts of the animals in Group II increased 41% in relation to their weight; 33% in the internal diameter and 14% in the external diameter of the LV cavity; and 24% in the thickness of the wall. Fibrosis of the myocardial tissue was observed in 75% of the animals of Group II; all the animals presented miocyte cytoplasmatic vacuolization; myocardial necrosis was present in 75% of the animals; and 87/% presented variation in the size of myocite nuclei. The presence of polymorphonuclear cells was also observed.
CONCLUSION: Doxorubicin was effective in the promotion of macro and microscopic alterations in the cardiac tissue of rats, possibly constituting a model for the experimental study of myocardiopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305878     DOI: 10.1590/s0102-86502010000200003

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  3 in total

1.  Comparative Therapeutic Potential of Cardioactive Glycosides in Doxorubicin Model of Heart Failure.

Authors:  Raquel da Silva Ferreira; Paula Bretas Ullmann Fernandes; Jéssica Pereira Oliveira da Cruz; Françoise Louanne Araújo Silva; Marthin Raboch Lempek; Gioavanni Naves Canta; Júlio César Cambraia Veado; Matheus Matioli Mantovani; Ana Flávia Machado Botelho; Marília Martins Melo
Journal:  Cardiovasc Toxicol       Date:  2021-10-16       Impact factor: 3.231

2.  Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model.

Authors:  Shafique Ahmad; Bibhu Prasad Panda; Kanchan Kohli; Mohammad Fahim; Kiran Dubey
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

3.  Cardioprotective effects of curcumin and carvacrol in doxorubicin-treated rats: Stereological study.

Authors:  Zahra Jafarinezhad; Ali Rafati; Farzaneh Ketabchi; Ali Noorafshan; Saied Karbalay-Doust
Journal:  Food Sci Nutr       Date:  2019-09-10       Impact factor: 2.863

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.